Xeris Biopharma Inc.
(XERS)
undefined
undefined%
At close: undefined
Ratios (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
PE Ratio | -1.30 | -0.48 | -0.61 | -0.43 | -0.50 | -0.85 | -0.39 | -0.71 |
PS Ratio | 0.49 | 0.41 | 0.53 | 1.06 | 2.28 | 20.77 | 6.59 | 8.66 |
PB Ratio | -11.93 | 1.00 | 1.28 | 0.55 | 1.36 | 0.68 | -0.18 | -0.29 |
P/FCF Ratio | -1.64 | -0.44 | -0.56 | -0.54 | -0.57 | -0.89 | -0.40 | -0.58 |
P/OCF Ratio | -1.72 | -0.44 | -0.56 | -0.55 | -0.57 | -0.91 | -0.42 | -0.58 |
OCF/S Ratio | -0.07 | -0.23 | -0.23 | -0.48 | -1.00 | -5.71 | -3.96 | -3.74 |
Debt / Equity Ratio | -7.17 | 1.04 | 0.49 | 0.23 | 0.43 | 0.11 | 0.00 | 0.00 |
Quick Ratio | 0.31 | 0.55 | 0.55 | 0.39 | 1.28 | 2.90 | 2.27 | 3.28 |
Current Ratio | 0.41 | 0.63 | 0.63 | 0.45 | 1.35 | 2.90 | 2.27 | 3.28 |
Asset Turnover | 0.51 | 0.32 | 0.32 | 0.16 | 0.13 | 0.02 | 0.03 | 0.03 |
Interest Coverage | -0.41 | -1.34 | -1.34 | -4.01 | -1.96 | -5.83 | -3328.63 | -1653.88 |
Return on Equity (ROE) | 917.94% | -209.49% | -209.49% | -128.87% | -269.96% | -79.68% | 45.92% | 41.36% |
Return on Assets (ROA) | -19.30% | -27.48% | -27.48% | -40.32% | -57.27% | -50.05% | -59.01% | -39.39% |
Return on Capital (ROIC) | -19.35% | -30.25% | -30.25% | -51.11% | -63.80% | -54.02% | -66.34% | -42.67% |
Dividend Yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Payout Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Profit Margin | 20.63% | 19.87% | 19.87% | 18.29% | 13.43% | 24.57% | 24.94% | 24.81% |
Net Profit Margin | -9.50% | -21.47% | -21.47% | -61.87% | -113.05% | -609.33% | -426.64% | -307.19% |